The TriVerse primary knee system is designed to offer similar surgical performance in both surgery centres and hospitals. Credit: Angelo Esslinger / Pixabay.

Exactech has obtained 510(k) clearance for its TriVerse primary knee replacement system from the US Food and Drug Administration (FDA).

The new primary knee system has been designed to provide cruciate retaining, anterior stabilised and posterior stabilised constructs.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It is intended to offer similar surgical performance in both surgery centres and hospitals.

The TriVerse primary knee replacement system adds to Exactech’s knee solutions portfolio, which includes primary and revision implants and instruments as well as the company’s balanced knee system and completely integrated Guided Personalized Surgery (GPS) platform.

The company stated that the insert bearings for the TriVerse knee system will be available in highly crosslinked vitamin E-stabilised polyethylene only.

See Also:

Exactech chief marketing officer and large joints senior vice-president Adam Hayden said: “The TriVerse primary knee system is positioned to be a powerful addition to Exactech’s portfolio that leverages proven design principles and data from hundreds of thousands of total knee replacement patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“TriVerse will offer orthopaedic surgeons an impactful solution that is developed using proven implant design features, intraoperative flexibility and a straightforward approach.”

The company plans a limited-scale commercialisation of the TriVerse primary knee replacement system from the second quarter of next year.

The new knee replacement system will be available alongside a compact set of adjustable mechanical instrumentation.

It is also planned to be compatible with Exactech’s ExactechGPS system in future.

Exactech is engaged in developing and producing implants, instrumentation and smart technologies for joint replacement surgery.

In July, the company introduced the Equinoxe Shoulder Planning App v2.1 in the US.